Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
The use of angiotensin receptor blockers such as losartan ha
2020-07-28

The use of angiotensin receptor blockers such as losartan have been shown to be effective in reducing cardiac fibrosis in a variety of models in animals and humans [34], [35], [36]. One limitation of angiotensin receptor blockers is the neuro-humoral negative feedback mechanism that leads to an incr
-
Introduction Since the recognition of AIDS in
2020-07-28

Introduction Since the recognition of AIDS in 1981 more than thirty-five years ago, nearly 70 million individuals have been infected with human immunodeficiency virus type 1 (HIV) and roughly half have died (http://www.unaids.org/en/resources/documents/2016/AIDS-by-the-numbers). Although the introd
-
The small molecule SB an inhibitor of p
2020-07-28

The small molecule SB203580, an inhibitor of p38α mitogen activated protein kinase (MAPK) [8], has also been reported to increase cardiomyocyte yield by over 2-folds [9]. Thus, the p38α MAPK pathway has been proposed as a second signaling cascade that RS 127445 HCl mg can be manipulated to improve
-
As there were no significant differences of cholesterol lowe
2020-07-28

As there were no significant differences of cholesterol-lowering efficacy among the three BBR doses, a lower dose than 50mg/kg·d might be equally effective. Thus, a dose optimization study should be conducted prior to clinical application. According to the dose translation from animals to humans [46
-
br Materials and methods br Results br Discussion Molecular
2020-07-27

Materials and methods Results Discussion Molecular markers have been clinically applied to the management of PCa, for example, Prolaris (46-gene test) from Myriad Genetics Inc., 22-gene test from Decipher Inc., and Genomic Prostate Score (17-gene test) from Oncotype DX. New markers are bein
-
The CysLT receptor is highly expressed
2020-07-27

The CysLT1 receptor is highly expressed in the lung, which may be relevant for its implication in pulmonary diseases like asthma. In fact, specific antagonists of the CysLT1 receptor (pranlukast, montelukast and zafirlukast) are used in the clinic to control bronchoconstriction and inflammation in m
-
Increased knowledge about CRC pathogenesis has
2020-07-27

Increased knowledge about CRC pathogenesis has provided new and remarkable treatments beyond the classical options of surgery, radiation and chemotherapy [11]. Despite these advances, chemotherapy remains the most important element of anti-cancer therapy. Chemotherapy, when initiated, is generally e
-
The CYP system is sensitive to the action
2020-07-27

The CYP450 system is sensitive to the action of xenobiotic substances that may increase its activity, and thus, it has been proposed as a biomarker for pollutants (Tagliari et al., 2004). This system is also very important from a toxicological point of view (Henczova et al., 2008). For these two abo
-
CXC chemokines not only have vital roles in development and
2020-07-27

CXC chemokines not only have vital roles in development and homeostasis but also participate in inflammatory responses in humans (Zlotnik and Yoshie, 2000, 2012; Raman et al., 2011). Conversely, the involvement of CXC chemokines in immune responses in fish species has only been sporadically reported
-
br Talasiu site The Talasiu site TO Mu is located
2020-07-27

Talasiu site The Talasiu site (TO-Mu-2) is located on the palaeoreef-limestone shoreline of the Fanga ‘Uta Lagoon, north of Lapaha Village, only 2.5 km south of Nukuleka Village which is regarded as the place of the initial Lapita landfall in Tonga (Burley et al., 2010) (Fig. 1). The site consist
-
The heterogeneity among studies that investigated
2020-07-27

The heterogeneity among studies that investigated the association of COMT Val158Met with alexithymia was also significant (Ham et al., 2005; Min et al., 2016; Swart et al., 2011; Zekioglu et al., 2014). The healthy status, drug effect, and other demographic variables also influenced one\'s ability o
-
br Materials and methods br
2020-07-25

Materials and methods Discussion To date, only a fraction of studies pertaining to analysis of avian semen have focused on the study of DNA, with the vast majority being associated with the effects of cryopreservation on sperm DNA integrity (Kotłowska et al., 2007, Madeddu et al., 2009, Partyk
-
In conclusion our findings suggested that
2020-07-25

In conclusion, our findings suggested that EP4 receptor activation triggers apoptosis in B-cell lymphoblasts. Our results also showed that EP4 receptor engagement inactivates NF-κB, which, in turn, sensitizes Ramos akt inhibitor to apoptosis induced by chemotherapeutic agents. EP4 receptor agonists
-
A previous report demonstrated that DA dependent oxidative
2020-07-25

A previous report demonstrated that DA-dependent oxidative stress may be the initial event in MA neurotoxicity (Cubells et al., 1994). Oxidative burdens at early stage might be a prerequisite for neurotoxic scenarios induced by 3-FMA, and they are in line with MA case (Shin et al., 2012, Shin et al.
-
In summary our data show
2020-07-25

In summary, our data show a novel mechanism: CPD-mediated autoprocessing of C difficile toxins regulates their proinflammatory activities. Thus, our study provides a new understanding of the molecular mechanisms of the pathogenesis of C difficile toxins and insights into designing new therapeutics a
14548 records 789/970 page Previous Next First page 上5页 786787788789790 下5页 Last page